BSE · 539428
Tejnaksh Healthcare Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹2 Cr with net profit ₹0 Cr — a 19.67% net margin, versus 15.76% the period before.
Shareholding
As of 2026-09-30
- Promoter73.83%
- Public26.17%
4,341 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.74× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #54 of 87 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,22,591 Cr | 54.13 | 11.55 | 21.14% | 8.12% |
| Max Healthcare Institute Ltd. | ₹92,184 Cr | 64.91 | 8.12 | 12.18% | 15.1% |
| Manipal Health Enterpri Limited | ₹89,630 Cr | 95.57 | 5.44 | 10.59% | 6.87% |
| Aster DM Quality Care Ltd. | ₹62,952 Cr | 113.55 | 8.46 | 7.11% | 7.23% |
| Fortis Healthcare Ltd. | ₹57,679 Cr | 53.73 | 5.51 | 9.91% | 10.48% |
| Global Health Limited | ₹39,095 Cr | 60.38 | 9.04 | 14.3% | 12.24% |
| Narayana Hrudayalaya Ltd. | ₹38,019 Cr | 42.01 | 7.61 | 17.17% | 8.36% |
| Dr. Lal Path Labs Ltd. | ₹33,452 Cr | 55.22 | 12.18 | 21.32% | 19.29% |
| Krishna Institute of Medical Sciences Ltd. | ₹30,646 Cr | 150.75 | 7.79 | 5.4% | 4.62% |
| Dr. Agarwal's Health Care Limited | ₹17,463 Cr | 97.66 | 7.81 | 8.04% | 7.61% |
| Tejnaksh Healthcare Limited(this company) | ₹28 Cr | 22.61 | 1 | 5.38% | 13.67% |
AI analysis
AI-generated · google/gemini-2.5-flashTejnaksh Healthcare Limited is listed with a market capitalization of Rs 29 Cr. The company reported a revenue of Rs 13.3 Cr and a profit margin of 11.31%. Its debt-to-equity ratio stands at 0.12.
Positives
- +Promoter holding is high at 73.8331% as of June 30, 2026.
- +The debt-to-equity ratio is low at 0.12.
- +No promoter shares are pledged, with a promoter pledge of 0%.
Negatives
- −The trailing twelve months revenue of Rs 13.3 Cr is relatively low for its market capitalization of Rs 29 Cr.
- −No revenue growth percentage is available in the provided data.
- −The dividend yield is 0%, indicating no dividend payouts.
- −No quarterly results have been disclosed since March 2026.
- −Institutional shareholding (DII and FII) is 0% as of June 30, 2026.
Financial Performance
Tejnaksh Healthcare Limited's recent annual performance shows varying results. In March 2025, the company reported a revenue of Rs 2.4 Cr and a net profit of Rs 0.75 Cr. For the quarter ending March 2026, revenue was Rs 2.55 Cr with a net profit of Rs 0.36 Cr. The company's overall revenue for the trailing twelve months is Rs 13.3 Cr.
Profitability & Returns
The company recorded an EPS of 0.6 and a book value of Rs 13.36. The return on equity (ROE) is reported as 452.4%, while the return on capital employed (ROCE) is 6.3496%. The profit margin for Tejnaksh Healthcare Limited stands at 11.31%.
Balance Sheet
Tejnaksh Healthcare Limited maintains a debt-to-equity ratio of 0.12, indicating a low reliance on debt financing. The company's book value per share is Rs 13.36. No dividend yield information is available as it is reported as 0%.
Ownership & Pledges
Public shareholding is recorded at 26.1669%. There is no promoter pledging reported, with promoter pledge at 0%.
Data as of — price: 2026-11-14 · financials: Sep 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Tejnaksh Healthcare Limitedshare price & fundamentals